Results

Total Results: 2,231 records

Showing results for "disease".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - higher risk disease. … Who dies of http://www.effectivehealthcare.ahrq.gov/reports/final.cfm 20 disease? … progression 36 months No statistically significant disease progression. … higher risk disease. … Do Not Know subjects with T2c disease but not in T2b subjects.
  2. effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - higher risk disease. … Who dies of http://www.effectivehealthcare.ahrq.gov/reports/final.cfm 20 disease? … progression 36 months No statistically significant disease progression. … higher risk disease. … Do Not Know subjects with T2c disease but not in T2b subjects.
  3. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
    January 01, 2012 - (The therapy has also recently been identified as being explored for other autoimmune diseases such … The rationale for this treatment stems from the fact that inflammatory bowel diseases are rare in developing … The rationale for this treatment stems from the fact that inflammatory bowel diseases are rare in developing … and other inflammatory bowel diseases. 8 It does not appear that the manufacturer intends to … Bethesda (MD): National Digestive Diseases Information Clearinghouse; [accessed 2011 Jun 6]. [4 p
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
    March 01, 2016 - , chronic kidney disease, bone disease, hyperlipidemia, cancer, depression, and neurocognitive impairment … This may lead to delayed diagnosis and greater disease burden for the individual. … Clinical infectious diseases : an official publication of the Infectious Diseases Society of America … HIV infection and cardiovascular disease. European heart journal. 2014;35(21):1373-1381. 12. … Psychological symptoms among persons 50 years of age and older living with HIV disease.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
    January 01, 2011 - were determined to have diabetes if they had two or more claims with International Classification of Diseases … The former set of ICD-9 codes represents the following macrovascular diseases: peripheral arterial … disease, myocardial infarction, heart failure, angina, and cere- brovascular disease. … The latter set of ICD-9 codes represents the following microvascular diseases: diabetic renal disease … , diabetic ophthalmic disease, and diabetic neurologic disease.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
    August 01, 2012 - – Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … – Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … – Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease? … • Coronary disease risk factors such as diabetes, chronic kidney disease, or other comorbid disease … Ischemic heart disease in women: facts and wishful thinking.
  7. Introduction (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
    February 01, 2009 - rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology Effective Health Care … Research Report Number 8 Introduction The treatment of rheumatoid arthritis (RA) with disease modifying … anti-rheumatic drugs (DMARDs) provides control of disease activity, slows joint erosions and improves … remission after 3 years.9,10 The lack of information on disease duration or disease activity measurements … The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis
  8. effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
    January 01, 2011 - Searches would include the disease, intervention, and terms for RCTs. … However, it is also sufficient to include the intervention, harms, and the disease of interest. … Arterial occlusive disease/ Peripheral vascular diseases/ Vascular diseases/ Atherosclerosis/ Cardiovascular … diseases/ Carotid artery diseases/ (((preserved adj left) or (stable adj cad) or (stable adj chd) or … adj lvef) or (normal adj ef)).mp 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 Terms for vascular diseases
  9. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
    April 01, 2012 - Horizon Scanning System – Potential High Impact Interventions Report Priority Area 13: Pulmonary Disease … ES-2 Pulmonary Disease, Including Asthma, Interventions ........................................... … ES-2 AHRQ Healthcare Horizon Scanning System AHRQ Priority Area 13 – Pulmonary Disease … Priority Area 13: Pulmonary Disease (including Asthma) 1. … Roflumilast (Daliresp) for treatment of chronic obstructive pulmonary disease Discussion Pulmonary
  10. effectivehealthcare.ahrq.gov/sites/default/files/branson-text.pdf
    October 13, 2011 - providers Slide 4 Characteristics of Patient Representatives § Have personal experience with the disease … § Are knowledgeable about treatment options and/or the science of the disease § Are able to be objective … groups may offer an opportunity to identify patients who might be underrepresented (such as for rare diseases … Advocacy experience § Ability to represent other patients/survivors § Knowledge and skills related to disease … area § Alternate disease experience § Work experience § Education § Interview representatives.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
    April 01, 2013 - 1.4.2 HIV infection 1.4.3 Portal hypertension 1.4.4 Congenital heart diseases … dysfunction 2.3 Valvular disease 3. … Pulmonary hypertension owing to lung diseases and/or hypoxemia 3.1 Chronic obstructive pulmonary … disease 3.2 Interstitial lung disease 3.3 Other pulmonary diseases with mixed restrictive … , or chronic obstructive pulmonary disease.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
    July 21, 2014 - such as age, sex, ethnicity, performance status, or medical comorbidities such as chronic kidney disease … We will exclude studies of biomarkers for prediction of treatment response or disease progression. … While identification of biomarkers for predicting treatment response and disease progression are important … Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer … heading word, keyword heading word, protocol supplementary concept word, rare disease
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
    December 01, 2009 - for markers of disease severity differences may remain between groups. … A 4- year trial of tiotropium in chronic obstructive pulmonary disease. … A 4- year trial of tiotropium in chronic obstructive pulmonary disease. … Tiotropium for stable chronic obstructive pulmonary disease: A meta- analysis. … A 4- year trial of tiotropium in chronic obstructive pulmonary disease.
  14. S158 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
    October 01, 2007 - Availability of information on disease outcome will affect choice of analytic strategies. … limitations when they are used to assess the role of medications in the etiology and management of chronic diseases … not have been completely controlled for in observational studies on pharmacopreven- tion of chronic diseases … These databases are, however, often the best source of information on the association between drugs and diseases … The treatment of unrelated disor- ders in patients with chronic medical diseases.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
    January 01, 2007 - Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors … Progression of atherosclerotic renovascular disease: A prospective population-based study. … Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting … stage 3A, baseline GFR 41-59 mL/min 2 Chronic kidney disease stage 3A, baseline GFR 30-40 mL/min 3 … ARAS, atherosclerotic renal artery stenosis; CKD, chronic kidney disease; CVD, cardiovascular disease
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
    January 01, 2008 - 09 1 Results of Topic Selection Process & Next Steps  Clostridium difficile-associated disease … in-hospital infection control, appropriate antibiotic prescribing, and effective treatment of existing disease … Clostridium difficile-associated disease (CDAD) Nomination Summary Document http://effectivehealthcare.ahrq.gov
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
    November 01, 2024 - , including lower limb amputations, blindness, chronic kidney disease, and cardiovascular diseases.5 … , gingival infection, periodontal disease, and tooth loss.4 They are among the most common chronic diseases … and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report … Periodontal Diseases and Cardiovascular Diseases, Diabetes, and Respiratory Diseases: Summary of the … Wrong study design Choi 2020 31882408 Impact of Treating Oral Disease on Preventing Vascular Diseases
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
    November 02, 2018 - Most individuals with dementia have Alzheimer’s disease (AD) as at least part of their underlying disease … ), or dementia due to a non-AD neurodegenerative disease. … Alzheimer's Disease. Centers for Disease Control and Prevention. … of Department of Health and Human Services Task Force on Alzheimer's Disease. … Pharmacological interventions for apathy in Alzheimer's disease.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
    March 13, 2012 - diagnosed with stage II disease are between 58 and 83 percent. … will develop recurrence or die from their disease. … In this report, prognostic outcomes relate to disease prognosis, generally measured by rate of disease … o For disease-free survival, how was it determined? … Centers for Disease Control and Prevention Web site. Public Health Genomics.
  20. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - Evolution and Variation The phenomenon of individuals affected by diseases establishing registries … history of a disease. … able to help generate evidence to support the development of treatment guidelines, especially for diseases … into care coordination and practice guidelines has become a model for other diseases.19, 73-84 Planning … Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: